Location History:
- Thousand Oaks, CA (US) (2014)
- Seattle, WA (US) (2017 - 2019)
Company Filing History:
Years Active: 2014-2019
Title: Innovations of Jane Talvenheimo
Introduction
Jane Talvenheimo is an accomplished inventor based in Seattle, WA. She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of four patents to her name, her work has the potential to impact pharmaceutical compositions and medicaments.
Latest Patents
Among her latest patents is a groundbreaking innovation related to carrier immunoglobulins. This patent discloses an isolated antigen binding protein, which includes antibodies or antibody fragments. The patent also covers pharmaceutical compositions and medicaments that comprise the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments, the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide.
Career Highlights
Jane Talvenheimo is currently employed at Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to further her research and development in the field of immunology and therapeutic proteins.
Collaborations
Throughout her career, Jane has collaborated with notable colleagues, including Kenneth William Walker and Yue-Sheng Li. These collaborations have enriched her research and contributed to her innovative projects.
Conclusion
Jane Talvenheimo's contributions to the field of biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical science and therapeutic applications.